EXEL

Exelixis (EXEL)

About Exelixis (EXEL)

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Details

Daily high

$33.68

Daily low

$33.11

Price at open

$33.30

52 Week High

$36.97

52 Week Low

$19.20

Market cap

9.5B

Dividend yield

0.00%

Volume

7.6M

Avg. volume

2.2M

P/E ratio

21.21

Exelixis News